Fundz

Rose Therapeutics reported raising $650,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATESep 02, 2022$650K of $1M raised

Amount Raised

$650,000

$650,000 sold, per SEC Form D (first sale Aug 22, 2022)

Round Type

Seed

NorristownBiotechnology

Quick answer

Rose Therapeutics raised $650,000 in a Seed round, dated August 22, 2022. Rose Therapeutics is based in Norristown, Pennsylvania, United States.

How much did Rose Therapeutics raise?
Rose Therapeutics raised $650,000 in a Seed round on August 22, 2022.
Where is Rose Therapeutics based and how big is it?
Rose Therapeutics is based in Norristown, Pennsylvania, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Rose Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Blaze Bioscience raised $25M on October 6, 2022.
  • Werewool raised $450K (Seed) on October 6, 2022.
  • Genetesis raised $18M (Series C) on October 6, 2022.
  • Covira raised an undisclosed amount (Funding Round) on October 6, 2022.
  • Inanovate raised $2.4M (Seed) on October 5, 2022.
  • Valitor raised an undisclosed amount (Series B) on October 5, 2022.

Who to call at Rose Therapeutics, and when

A new round usually means Rose Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Rose Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rose Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rose Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rose Therapeutics

Location

20 WEST MAIN STREET, 3RD FLOOR

Norristown, Pennsylvania, United States

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rose Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Rose Therapeutics's next move

See what Strategic adds

Rose Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.